Petr Kocis

Title: Petr Kocis: Innovator in Peptide Analog Research

Introduction

Petr Kocis is a notable inventor based in Prague, Czech Republic. He has made significant contributions to the field of peptide research, particularly through his innovative work on serum thymic factor peptide analogs. His research has implications for various medical applications, showcasing the importance of peptide analogs in therapeutic contexts.

Latest Patents

Kocis holds a patent for "Serum thymic factor peptide analogs and process for the preparation." This patent discloses novel peptide analogs of the serum thymic factor, which are structurally modified compared to the natural substance. The modifications occur in both the N-terminal and C-terminal parts, as well as within the amino-acid sequence, corresponding to the general formula I. He has 1 patent to his name, reflecting his innovative contributions to the field.

Career Highlights

Petr Kocis is associated with Spofa, Spojene Podniky Pro Zdravotnickou Vyrobu, a company known for its focus on healthcare products. His work at Spofa has allowed him to explore and develop peptide analogs that could lead to advancements in medical treatments. Kocis's dedication to research and development has positioned him as a key figure in his field.

Collaborations

Some of his notable coworkers include Evzen Kasafirek and Martin Cerny. Their collaborative efforts contribute to the innovative environment at Spofa, fostering advancements in peptide research and development.

Conclusion

Petr Kocis is a distinguished inventor whose work on serum thymic factor peptide analogs has the potential to impact medical science significantly. His contributions, along with his collaborations, highlight the importance of innovation in the field of healthcare.